Fatty acid synthase (FASN), one of the most important enzymes involved in fatty acid biosynthesis, is consistently overexpressed in prostate cancer tissues compared with the adjacent normal tissue [30], and the FASN inhibitor has been shown to suppress the progression of cancers, including prostate cancer [29,31]. The gene discussed is FASN; the disease is Familial prostate cancer.